These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 26586215)

  • 1. An update on the treatment of canine atopic dermatitis.
    Saridomichelakis MN; Olivry T
    Vet J; 2016 Jan; 207():29-37. PubMed ID: 26586215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
    Little PR; King VL; Davis KR; Cosgrove SB; Stegemann MR
    Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis.
    Olivry T; DeBoer DJ; Favrot C; Jackson HA; Mueller RS; Nuttall T; Prélaud P;
    Vet Dermatol; 2010 Jun; 21(3):233-48. PubMed ID: 20456716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life.
    Cosgrove SB; Cleaver DM; King VL; Gilmer AR; Daniels AE; Wren JA; Stegemann MR
    Vet Dermatol; 2015 Jun; 26(3):171-9, e35. PubMed ID: 25688708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA).
    Olivry T; DeBoer DJ; Favrot C; Jackson HA; Mueller RS; Nuttall T; Prélaud P;
    BMC Vet Res; 2015 Aug; 11():210. PubMed ID: 26276051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency of urinary tract infection and subclinical bacteriuria in dogs with allergic dermatitis treated with oclacitinib: a prospective study.
    Simpson AC; Schissler JR; Rosychuk RAW; Moore AR
    Vet Dermatol; 2017 Oct; 28(5):485-e113. PubMed ID: 28513001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia.
    Gadeyne C; Little P; King VL; Edwards N; Davis K; Stegemann MR
    Vet Dermatol; 2014 Dec; 25(6):512-8, e86. PubMed ID: 25109820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An embarrassment of riches: An update on the symptomatic treatment of canine atopic dermatitis.
    Gortel K
    Can Vet J; 2018 Sep; 59(9):1013-1016. PubMed ID: 30197448
    [No Abstract]   [Full Text] [Related]  

  • 9. A pilot study on the effect of oclacitinib on epicutaneous sensitization and transepidermal water loss in a colony of atopic beagle dogs.
    Marsella R; Ahrens K
    Vet Dermatol; 2018 Oct; 29(5):439-e146. PubMed ID: 29926994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot evaluation of Enterococcus faecium SF68 as adjunctive therapy for oclacitinib-responsive adult atopic dermatitis in dogs.
    Yamazaki C; Rosenkrantz W; Griffin C
    J Small Anim Pract; 2019 Aug; 60(8):499-506. PubMed ID: 31257599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of various treatment options for canine atopic dermatitis: a blinded, randomized, controlled study in a colony of research atopic beagle dogs.
    Marsella R; Ahrens K; Wilkes R; Trujillo A; Dorr M
    Vet Dermatol; 2020 Aug; 31(4):284-e69. PubMed ID: 32301565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.
    Cosgrove SB; Wren JA; Cleaver DM; Walsh KF; Follis SI; King VI; Tena JK; Stegemann MR
    Vet Dermatol; 2013 Dec; 24(6):587-97, e141-2. PubMed ID: 24581322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled, double-blind study evaluating the effect of orally administered polyunsaturated fatty acids on the oclacitinib dose for atopic dogs.
    Schäfer L; Thom N
    Vet Dermatol; 2024 Aug; 35(4):408-417. PubMed ID: 38465482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of oclacitinib in the management of ischaemic dermatopathy in four dogs.
    Levy BJ; Linder KE; Olivry T
    Vet Dermatol; 2019 Jun; 30(3):201-e63. PubMed ID: 31006925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis.
    Nuttall TJ; McEwan NA; Bensignor E; Cornegliani L; Löwenstein C; Rème CA
    Vet Dermatol; 2012 Feb; 23(1):4-10, e1-2. PubMed ID: 21718368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis.
    Cosgrove SB; Wren JA; Cleaver DM; Martin DD; Walsh KF; Harfst JA; Follis SL; King VL; Boucher JF; Stegemann MR
    Vet Dermatol; 2013 Oct; 24(5):479-e114. PubMed ID: 23829933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oclacitinib in feline nonflea-, nonfood-induced hypersensitivity dermatitis: results of a small prospective pilot study of client-owned cats.
    Ortalda C; Noli C; Colombo S; Borio S
    Vet Dermatol; 2015 Aug; 26(4):235-e52. PubMed ID: 25940959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Owner assessment of therapeutic interventions for canine atopic dermatitis: a long-term retrospective analysis.
    Dell DL; Griffin CE; Thompson LA; Griffies JD
    Vet Dermatol; 2012 Jun; 23(3):228-e47. PubMed ID: 22575021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blinded, randomized, controlled, crossover evaluation of a zinc methionine supplement as an adjunctive treatment for canine atopic dermatitis.
    McFadden RA; Heinrich NA; Haarstad AC; Tomlinson DJ
    Vet Dermatol; 2017 Dec; 28(6):569-e138. PubMed ID: 28736909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a human generic formulation of ciclosporin in the treatment of canine atopic dermatitis with in vitro assessment of the functional capacity of phagocytic cells.
    Kovalik M; Taszkun I; Pomorski Z; Kozak M; Pomorska D; Szczepanik M; Wilkolek P; Palenik L; Shaw DJ; van den Broek AH; Thoday KL
    Vet Rec; 2011 May; 168(20):537. PubMed ID: 21558130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.